tobramycin [8359]



tobramycin


SMILES NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O
InChIKey NLVFBUXFDBBNBW-PBSUHMDJSA-N

Chemical Properties

Hydrogen bond acceptors 14
Hydrogen bond donors 10
Rotatable bonds 6
Log P -6.296
Molecular weight (Da) 467.3
Stereochemistry info full


Bioactivities

Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database
Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database

tobramycin


Drug properties

Molecular type Small molecule
Physiological/Surrogate Surrogate
Approved drug Yes

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0


Compound is not listed as a drug.